 | • レポートコード：QFJ1-3986 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、細胞＆遺伝子治療製造QCの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（安全性試験、純度試験、効力試験、同一性試験、安定性試験）、用途別市場規模（精密治療、生物研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・細胞＆遺伝子治療製造QCの市場動向 ・企業の競争状況、市場シェア ・細胞＆遺伝子治療製造QCの種類別市場規模と予測2016-2027（安全性試験、純度試験、効力試験、同一性試験、安定性試験） ・細胞＆遺伝子治療製造QCの用途別市場規模と予測2016-2027（精密治療、生物研究所） ・細胞＆遺伝子治療製造QCの北米市場規模2016-2027（アメリカ、カナダ） ・細胞＆遺伝子治療製造QCの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・細胞＆遺伝子治療製造QCのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・細胞＆遺伝子治療製造QCの中南米市場規模2016-2027（メキシコ、ブラジル） ・細胞＆遺伝子治療製造QCの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bio-Techne Corporation、BioMerieux SA、Catalent, Inc.、Charles River Laboratories International Inc.、Eurofins Scientific SE、F. Hoffmann-La Roche Ltd、Intertek Group plc、Lonza Group AG、Merck KGaA、Sartorius AG、SGS S.A.、Sistemic Scotland Limited、Thermo Fisher Scientific Inc.、Vigene Biosciences, Inc.、WuXi AppTec） ・結論 |
Market Analysis and Insights: Global Cell and Gene Therapy Manufacturing QC Market
The global Cell and Gene Therapy Manufacturing QC market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell and Gene Therapy Manufacturing QC market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell and Gene Therapy Manufacturing QC market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell and Gene Therapy Manufacturing QC market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell and Gene Therapy Manufacturing QC market.
Global Cell and Gene Therapy Manufacturing QC Scope and Market Size
Cell and Gene Therapy Manufacturing QC market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy Manufacturing QC market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Safety Testing
Purity Testing
Potency Testing
Identity Testing
Stability Testing
Segment by Application
Precision Therapy
Biological Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bio-Techne Corporation
BioMerieux SA
Catalent, Inc.
Charles River Laboratories International Inc.
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Intertek Group plc
Lonza Group AG
Merck KGaA
Sartorius AG
SGS S.A.
Sistemic Scotland Limited
Thermo Fisher Scientific Inc.
Vigene Biosciences, Inc.
WuXi AppTec
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Safety Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Stability Testing
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Precision Therapy
1.3.3 Biological Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing QC Market Perspective (2016-2027)
2.2 Cell and Gene Therapy Manufacturing QC Growth Trends by Regions
2.2.1 Cell and Gene Therapy Manufacturing QC Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell and Gene Therapy Manufacturing QC Historic Market Share by Regions (2016-2021)
2.2.3 Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Regions (2022-2027)
2.3 Cell and Gene Therapy Manufacturing QC Industry Dynamic
2.3.1 Cell and Gene Therapy Manufacturing QC Market Trends
2.3.2 Cell and Gene Therapy Manufacturing QC Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing QC Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing QC Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue (2016-2021)
3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2016-2021)
3.2 Global Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing QC Revenue
3.4 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing QC Revenue in 2020
3.5 Cell and Gene Therapy Manufacturing QC Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing QC Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing QC Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Type (2016-2021)
4.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2022-2027)
5 Cell and Gene Therapy Manufacturing QC Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Application (2016-2021)
5.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
6.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type
6.2.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
6.2.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
6.2.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application
6.3.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
6.3.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
6.3.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
6.4 North America Cell and Gene Therapy Manufacturing QC Market Size by Country
6.4.1 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
6.4.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
7.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type
7.2.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
7.2.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
7.2.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application
7.3.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
7.3.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
7.3.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
7.4 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country
7.4.1 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
7.4.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type
8.2.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application
8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region
8.4.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
9.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type
9.2.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
9.2.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
9.2.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
9.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application
9.3.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
9.3.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
9.3.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
9.4 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country
9.4.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
9.4.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size (2016-2027)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type
10.2.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application
10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country
10.4.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Details
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Introduction
11.1.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.1.5 Bio-Techne Corporation Recent Development
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Details
11.2.2 BioMerieux SA Business Overview
11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Introduction
11.2.4 BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.2.5 BioMerieux SA Recent Development
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Details
11.3.2 Catalent, Inc. Business Overview
11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.3.4 Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.3.5 Catalent, Inc. Recent Development
11.4 Charles River Laboratories International Inc.
11.4.1 Charles River Laboratories International Inc. Company Details
11.4.2 Charles River Laboratories International Inc. Business Overview
11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.4.4 Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.4.5 Charles River Laboratories International Inc. Recent Development
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Details
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Introduction
11.5.4 Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.5.5 Eurofins Scientific SE Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Details
11.6.2 F. Hoffmann-La Roche Ltd Business Overview
11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Introduction
11.6.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Intertek Group plc
11.7.1 Intertek Group plc Company Details
11.7.2 Intertek Group plc Business Overview
11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Introduction
11.7.4 Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.7.5 Intertek Group plc Recent Development
11.8 Lonza Group AG
11.8.1 Lonza Group AG Company Details
11.8.2 Lonza Group AG Business Overview
11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Introduction
11.8.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.8.5 Lonza Group AG Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Introduction
11.9.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.9.5 Merck KGaA Recent Development
11.10 Sartorius AG
11.10.1 Sartorius AG Company Details
11.10.2 Sartorius AG Business Overview
11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Introduction
11.10.4 Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.10.5 Sartorius AG Recent Development
11.11 SGS S.A.
11.11.1 SGS S.A. Company Details
11.11.2 SGS S.A. Business Overview
11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Introduction
11.11.4 SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.11.5 SGS S.A. Recent Development
11.12 Sistemic Scotland Limited
11.12.1 Sistemic Scotland Limited Company Details
11.12.2 Sistemic Scotland Limited Business Overview
11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Introduction
11.12.4 Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.12.5 Sistemic Scotland Limited Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Details
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
11.14 Vigene Biosciences, Inc.
11.14.1 Vigene Biosciences, Inc. Company Details
11.14.2 Vigene Biosciences, Inc. Business Overview
11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.14.4 Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.14.5 Vigene Biosciences, Inc. Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Details
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Introduction
11.15.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
11.15.5 WuXi AppTec Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Safety Testing
Table 3. Key Players of Purity Testing
Table 4. Key Players of Potency Testing
Table 5. Key Players of Identity Testing
Table 6. Key Players of Stability Testing
Table 7. Global Cell and Gene Therapy Manufacturing QC Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cell and Gene Therapy Manufacturing QC Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cell and Gene Therapy Manufacturing QC Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cell and Gene Therapy Manufacturing QC Market Share by Regions (2016-2021)
Table 11. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cell and Gene Therapy Manufacturing QC Market Share by Regions (2022-2027)
Table 13. Cell and Gene Therapy Manufacturing QC Market Trends
Table 14. Cell and Gene Therapy Manufacturing QC Market Drivers
Table 15. Cell and Gene Therapy Manufacturing QC Market Challenges
Table 16. Cell and Gene Therapy Manufacturing QC Market Restraints
Table 17. Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cell and Gene Therapy Manufacturing QC Market Share by Players (2016-2021)
Table 19. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2020)
Table 20. Ranking of Global Top Cell and Gene Therapy Manufacturing QC Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
Table 24. Date of Enter into Cell and Gene Therapy Manufacturing QC Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2016-2021)
Table 28. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cell and Gene Therapy Manufacturing QC Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2016-2021)
Table 32. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bio-Techne Corporation Company Details
Table 65. Bio-Techne Corporation Business Overview
Table 66. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product
Table 67. Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 68. Bio-Techne Corporation Recent Development
Table 69. BioMerieux SA Company Details
Table 70. BioMerieux SA Business Overview
Table 71. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product
Table 72. BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 73. BioMerieux SA Recent Development
Table 74. Catalent, Inc. Company Details
Table 75. Catalent, Inc. Business Overview
Table 76. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 77. Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 78. Catalent, Inc. Recent Development
Table 79. Charles River Laboratories International Inc. Company Details
Table 80. Charles River Laboratories International Inc. Business Overview
Table 81. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product
Table 82. Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 83. Charles River Laboratories International Inc. Recent Development
Table 84. Eurofins Scientific SE Company Details
Table 85. Eurofins Scientific SE Business Overview
Table 86. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product
Table 87. Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 88. Eurofins Scientific SE Recent Development
Table 89. F. Hoffmann-La Roche Ltd Company Details
Table 90. F. Hoffmann-La Roche Ltd Business Overview
Table 91. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product
Table 92. F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 93. F. Hoffmann-La Roche Ltd Recent Development
Table 94. Intertek Group plc Company Details
Table 95. Intertek Group plc Business Overview
Table 96. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product
Table 97. Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 98. Intertek Group plc Recent Development
Table 99. Lonza Group AG Company Details
Table 100. Lonza Group AG Business Overview
Table 101. Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 102. Lonza Group AG Recent Development
Table 103. Merck KGaA Company Details
Table 104. Merck KGaA Business Overview
Table 105. Merck KGaA Cell and Gene Therapy Manufacturing QC Product
Table 106. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 107. Merck KGaA Recent Development
Table 108. Sartorius AG Company Details
Table 109. Sartorius AG Business Overview
Table 110. Sartorius AG Cell and Gene Therapy Manufacturing QC Product
Table 111. Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 112. Sartorius AG Recent Development
Table 113. SGS S.A. Company Details
Table 114. SGS S.A. Business Overview
Table 115. SGS S.A. Cell and Gene Therapy Manufacturing QC Product
Table 116. SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 117. SGS S.A. Recent Development
Table 118. Sistemic Scotland Limited Company Details
Table 119. Sistemic Scotland Limited Business Overview
Table 120. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product
Table 121. Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 122. Sistemic Scotland Limited Recent Development
Table 123. Thermo Fisher Scientific Inc. Company Details
Table 124. Thermo Fisher Scientific Inc. Business Overview
Table 125. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product
Table 126. Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 127. Thermo Fisher Scientific Inc. Recent Development
Table 128. Vigene Biosciences, Inc. Company Details
Table 129. Vigene Biosciences, Inc. Business Overview
Table 130. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 131. Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 132. Vigene Biosciences, Inc. Recent Development
Table 133. WuXi AppTec Company Details
Table 134. WuXi AppTec Business Overview
Table 135. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product
Table 136. WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2016-2021) & (US$ Million)
Table 137. WuXi AppTec Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Manufacturing QC Market Share by Type: 2020 VS 2027
Figure 2. Safety Testing Features
Figure 3. Purity Testing Features
Figure 4. Potency Testing Features
Figure 5. Identity Testing Features
Figure 6. Stability Testing Features
Figure 7. Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2020 VS 2027
Figure 8. Precision Therapy Case Studies
Figure 9. Biological Research Case Studies
Figure 10. Cell and Gene Therapy Manufacturing QC Report Years Considered
Figure 11. Global Cell and Gene Therapy Manufacturing QC Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cell and Gene Therapy Manufacturing QC Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cell and Gene Therapy Manufacturing QC Market Share by Regions: 2020 VS 2027
Figure 14. Global Cell and Gene Therapy Manufacturing QC Market Share by Regions (2022-2027)
Figure 15. Global Cell and Gene Therapy Manufacturing QC Market Share by Players in 2020
Figure 16. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue in 2020
Figure 18. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2016-2021)
Figure 19. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2022-2027)
Figure 20. North America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cell and Gene Therapy Manufacturing QC Market Share by Type (2016-2027)
Figure 22. North America Cell and Gene Therapy Manufacturing QC Market Share by Application (2016-2027)
Figure 23. North America Cell and Gene Therapy Manufacturing QC Market Share by Country (2016-2027)
Figure 24. United States Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cell and Gene Therapy Manufacturing QC Market Share by Type (2016-2027)
Figure 28. Europe Cell and Gene Therapy Manufacturing QC Market Share by Application (2016-2027)
Figure 29. Europe Cell and Gene Therapy Manufacturing QC Market Share by Country (2016-2027)
Figure 30. Germany Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Region (2016-2027)
Figure 40. China Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cell and Gene Therapy Manufacturing QC Market Share by Type (2016-2027)
Figure 48. Latin America Cell and Gene Therapy Manufacturing QC Market Share by Application (2016-2027)
Figure 49. Latin America Cell and Gene Therapy Manufacturing QC Market Share by Country (2016-2027)
Figure 50. Mexico Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Share by Country (2016-2027)
Figure 56. Turkey Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bio-Techne Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 60. BioMerieux SA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 61. Catalent, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 62. Charles River Laboratories International Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 63. Eurofins Scientific SE Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 65. Intertek Group plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 66. Lonza Group AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 67. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 68. Sartorius AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 69. SGS S.A. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 70. Sistemic Scotland Limited Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 71. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 72. Vigene Biosciences, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 73. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界のタバコ代謝遺伝子検査市場規模・現状・予測（2021年-2027年） A detection method for cigarette metabolism Market Analysis and Insights: Global Cigarette Metabolism Gene Testing Market The global Cigarette Metabolism Gene Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…- 世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell and Gene Therapy Tools and Reagents Market The global Cell and Gene Therapy Tools and Reagents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
- 世界の才能遺伝子検査市場規模・現状・予測（2021年-2027年） A method for detecting children's talent Market Analysis and Insights: Global Talent Genetic Testing Market The global Talent Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in a…
- 世界の遺伝子検出用個別化癌治療市場規模・現状・予測（2021年-2027年） A method to provide patients with individualized treatment of cancer tumors Market Analysis and Insights: Global Gene Detection for Individualized Cancer Therapy Market The global Gene Detection for Individualized Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX m…
- 世界の細胞＆遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting …